MHRA Threat to clinics In communication with the MHRA, they also stated: However, we do have concerns about the level of clinical oversight present in IV vitamin therapy and injection services in general and the appropriacy of such services is currently under review. This review, if deciding on stopping treatment of B12 injections by clinics who do comply with the ridiculous rules of the MHRA, would not only negatively impact the companies and individuals who give B12 injections, but also to the people who rely on them to keep functioning both physically and mentally
Its use should be limited to research applications, and any consideration of peptide therapy should be conducted under professional supervision, with a thorough evaluation of potential risks and benefits
We included products with various B12 levels that work for different dosage needs, as well as vegans, vegetarians, and those with allergies
Any references to biological activity are provided strictly for research context and must not be interpreted as claims of safety, efficacy, or intended human use